Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Bevacizumab plus FOLFOX-4 regimen represents the first-line therapy in patients affected by metastatic colorectal cancer (mCRC). Hyperthermia has been considered an effective ancillary treatment for cancer therapy through several anti-tumor mechanisms, sharing with Bevacizumab the inhibition of angi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Ranieri, Girolamo, Laface, Carmelo, Laforgia, Mariarita, De Summa, Simona, Porcelli, Mariangela, Macina, Francesco, Ammendola, Michele, Molinari, Pasquale, Lauletta, Gianfranco, Di Palo, Alessandra, Rubini, Giuseppe, Ferrari, Cristina, Gadaleta, Cosmo Damiano
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7670056/
https://ncbi.nlm.nih.gov/pubmed/33224885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.590707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars